Astrocytic atrophy as a pathological feature of Parkinson’s disease with LRRK2 mutation
Abstract The principal hallmark of Parkinson’s disease (PD) is the selective neurodegeneration of dopaminergic neurones. Mounting evidence suggests that astrocytes may contribute to dopaminergic neurodegeneration through decreased homoeostatic support and deficient neuroprotection. In this study, we...
Main Authors: | Paula Ramos-Gonzalez, Susana Mato, Juan Carlos Chara, Alexei Verkhratsky, Carlos Matute, Fabio Cavaliere |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-03-01
|
Series: | npj Parkinson's Disease |
Online Access: | https://doi.org/10.1038/s41531-021-00175-w |
Similar Items
-
Pathological Functions of LRRK2 in Parkinson’s Disease
by: Ga Ram Jeong, et al.
Published: (2020-11-01) -
Pathologic Potential of Astrocytic Vesicle Traffic: New Targets to Treat Neurologic Diseases?
by: Nina Vardjan, et al.
Published: (2015-04-01) -
LRRK2 G2019S Mutation: Prevalence and Clinical Features in Moroccans with Parkinson’s Disease
by: Ahmed Bouhouche, et al.
Published: (2017-01-01) -
Early Astrocytic Atrophy in the Entorhinal Cortex of a Triple Transgenic Animal Model of Alzheimer's Disease
by: Chia-Yu Yeh, et al.
Published: (2011-11-01) -
Functional properties of LRRK2 mutations in Taiwanese Parkinson disease
by: Kuo-Hsuan Chang, et al.
Published: (2017-03-01)